Validation of the Italian translation of the perceived stigma scale and resilience assessment in inflammatory bowel disease patients.


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
21 Oct 2021
Historique:
received: 14 02 2021
revised: 21 03 2021
accepted: 11 10 2021
entrez: 10 11 2021
pubmed: 11 11 2021
medline: 12 11 2021
Statut: ppublish

Résumé

Stigmatization is the separation of an individual from a group due to aspects that make them different. Resilience may in turn influence the perception of stigma. Patients with inflammatory bowel disease (IBD) are susceptible to stigma, although data are very limited. To validate an Italian translation of the IBD perceived stigma scale (PSS) in relation to patients' resilience. Consecutive IBD outpatients were prospectively enrolled (December 2018-September 2019) in an Italian, tertiary referral, IBD center. Clinical and demographic data were collected. Stigma and resilience were evaluated through the IBD-PSS and the 25-item Connor-Davidson Resilience Scale, respectively. The International Quality of Life Assessment Project approach was followed to translate the IBD-PSS into Italian and to establish data quality. Higher scores represent greater perceived stigma and resilience. Multivariable analysis for factors associated with greater stigma was computed. Overall, 126 IBD patients (mean age 46.1 ± 16.9) were enrolled. The International Quality of Life Assessment criteria for acceptable psychometric properties of the scale were satisfied, with optimal data completeness. There was no ceiling effect, whilst floor effect was present (7.1%). The discriminant validity and the internal consistency reliability were good (Cronbach alpha = 0.87). The overall internal consistency was 95%, and the test-retest reliability was excellent 0.996. The median PSS score was 0.45 (0.20-0.85). Resilience negatively correlated with perceived stigma (Spearman's correlation = -0.18, 95% confidence intervals: -0.42-0.08, We herein validated the Italian translation of the PSS scale, also demonstrating that resilience negatively impacts perceived stigma.

Sections du résumé

BACKGROUND BACKGROUND
Stigmatization is the separation of an individual from a group due to aspects that make them different. Resilience may in turn influence the perception of stigma. Patients with inflammatory bowel disease (IBD) are susceptible to stigma, although data are very limited.
AIM OBJECTIVE
To validate an Italian translation of the IBD perceived stigma scale (PSS) in relation to patients' resilience.
METHODS METHODS
Consecutive IBD outpatients were prospectively enrolled (December 2018-September 2019) in an Italian, tertiary referral, IBD center. Clinical and demographic data were collected. Stigma and resilience were evaluated through the IBD-PSS and the 25-item Connor-Davidson Resilience Scale, respectively. The International Quality of Life Assessment Project approach was followed to translate the IBD-PSS into Italian and to establish data quality. Higher scores represent greater perceived stigma and resilience. Multivariable analysis for factors associated with greater stigma was computed.
RESULTS RESULTS
Overall, 126 IBD patients (mean age 46.1 ± 16.9) were enrolled. The International Quality of Life Assessment criteria for acceptable psychometric properties of the scale were satisfied, with optimal data completeness. There was no ceiling effect, whilst floor effect was present (7.1%). The discriminant validity and the internal consistency reliability were good (Cronbach alpha = 0.87). The overall internal consistency was 95%, and the test-retest reliability was excellent 0.996. The median PSS score was 0.45 (0.20-0.85). Resilience negatively correlated with perceived stigma (Spearman's correlation = -0.18, 95% confidence intervals: -0.42-0.08,
CONCLUSION CONCLUSIONS
We herein validated the Italian translation of the PSS scale, also demonstrating that resilience negatively impacts perceived stigma.

Identifiants

pubmed: 34754158
doi: 10.3748/wjg.v27.i39.6647
pmc: PMC8554395
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6647-6658

Informations de copyright

©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors of this manuscript having no conflicts of interest to disclose.

Références

Inflamm Bowel Dis. 2009 Aug;15(8):1224-32
pubmed: 19180581
Qual Life Res. 2011 Nov;20(9):1391-9
pubmed: 21424542
Int J Nurs Sci. 2018 Dec 26;6(2):127-133
pubmed: 31406881
Br J Psychiatry. 1976 May;128:446-50
pubmed: 1276548
Clin Rehabil. 2019 Nov;33(11):1800-1809
pubmed: 31307214
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
BMJ. 2004 Jun 19;328(7454):1470
pubmed: 15194599
J Clin Epidemiol. 1998 Nov;51(11):913-23
pubmed: 9817108
J Clin Epidemiol. 1998 Nov;51(11):945-52
pubmed: 9817111
Clin Exp Gastroenterol. 2016 Mar 07;9:49-58
pubmed: 27022294
Dig Dis Sci. 1989 Sep;34(9):1379-86
pubmed: 2766905
Dis Esophagus. 2017 Jul 1;30(7):1-8
pubmed: 28475723
EMBO Rep. 2016 Sep;17(9):1250-3
pubmed: 27470237
Am J Gastroenterol. 2001 Jun;96(6):1822-30
pubmed: 11419836
Res Aging. 2015 May;37(4):335-60
pubmed: 25651574
Psychol Health Med. 2009 May;14(3):367-74
pubmed: 19444714
Intern Emerg Med. 2020 Mar;15(2):211-223
pubmed: 31893346
Curr Neuropharmacol. 2010 Dec;8(4):335-58
pubmed: 21629442
BMJ Open. 2016 Jul 13;6(7):e011453
pubmed: 27412106
Inflamm Bowel Dis. 2021 May 17;27(6):791-796
pubmed: 32696966
Lancet. 1980 Mar 8;1(8167):514
pubmed: 6102236
Gastroenterology. 2002 Feb;122(2):512-30
pubmed: 11832465
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
J Family Reprod Health. 2015 Nov;9(4):164-71
pubmed: 27047562
Arq Gastroenterol. 2019 Aug 13;56(2):131-140
pubmed: 31460575
N Engl J Med. 2005 Dec 8;353(23):2462-76
pubmed: 16339095
Depress Anxiety. 2003;18(2):76-82
pubmed: 12964174
Psychiatry J. 2014;2014:694565
pubmed: 24967300

Auteurs

Sara Cococcia (S)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Marco Vincenzo Lenti (MV)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy. marco.lenti@unipv.it.

Caterina Mengoli (C)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Catherine Klersy (C)

Service of Biometry & Statistics, Foundation IRCCS Policlinico San Matteo, Pavia 27100, Lombardia, Italy.

Federica Borrelli de Andreis (F)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Matteo Secco (M)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Jihane Ghorayeb (J)

Psychology, Zayed University, Dubai 00000, United Arab Emirates.

Mariangela Delliponti (M)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Gino Roberto Corazza (GR)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Antonio Di Sabatino (A)

First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia 27100, Lombardia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH